{
  "figure_1": "Odds of COVID-19 infection in patients with recent versus all-time diagnosis of hematologic malignancies, adjusted for age, gender, race and potential COVID-19 risk factors (cardiovascular diseases, type 2 diabetes, obesity, chronic kidney diseases, chronic obstructive pulmonary disease (COPD), asthma, substance use disorders, cancer therapy (chemotherapy, radiotherapy, immunotherapy), transplant procedure (bone marrow transplant, solid organ transplant) and nursing home stay status.",
  "figure_2": "Effects of demographics on odds of COVID-19 infection among patients with recently diagnosed hematologic malignancies, adjusted for other demographics and potential COVID-19 risk factors (cardiovascular diseases, type 2 diabetes, obesity, chronic kidney diseases, chronic obstructive pulmonary disease (COPD), asthma, substance use disorders, cancer therapy (chemotherapy, radiotherapy, immunotherapy), transplant procedure (bone marrow transplant, solid organ transplant) and nursing home stay status.",
  "figure_3": "Hospitalization and death rates among three populations: patients with both recent diagnosis of hematologic malignancies and COVID-19, COVID-19 patients without hematologic malignancies, hematologic malignancy patients without COVID-19. ***: p < 0.0001; **: p < 0.001; ns: not statistically significant. The SNOMED-CT concepts “Hospital admission (procedure)” (ID 32485007) was used to obtain hospitalization status from patient EHRs. Explorys regularly imports from the Social Security Death index for the “deceased” status."
}